KILITCH DRUGS (INDIA)
|
KILITCH DRUGS (INDIA) Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.08 | 6.71 | 4.73 | 2.37 | 0.55 |
| CEPS(Rs) | 10.52 | 7.59 | 5.57 | 3.71 | 1.84 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 109.40 | 93.85 | 87.43 | 81.82 | 75.85 |
| Tax Rate(%) | 29.86 | 31.06 | 35.37 | 26.43 | 47.61 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 15.72 | 12.70 | 9.19 | 7.74 | -0.01 |
| EBIT Margin(%) | 16.45 | 12.25 | 9.58 | 8.73 | 4.77 |
| Pre Tax Margin(%) | 12.54 | 8.61 | 8.42 | 7.45 | 3.01 |
| PAT Margin (%) | 8.79 | 5.93 | 5.44 | 5.48 | 1.58 |
| Cash Profit Margin (%) | 10.96 | 8.48 | 7.60 | 8.38 | 5.32 |
| Performance Ratios | |||||
| ROA(%) | 5.97 | 3.89 | 3.03 | 2.19 | 0.59 |
| ROE(%) | 8.43 | 5.86 | 4.73 | 3.09 | 0.71 |
| ROCE(%) | 13.30 | 10.26 | 7.26 | 4.40 | 1.95 |
| Asset Turnover(x) | 0.68 | 0.66 | 0.56 | 0.40 | 0.38 |
| Sales/Fixed Asset(x) | 1.38 | 1.27 | 1.28 | 0.97 | 0.76 |
| Working Capital/Sales(x) | 1.89 | 2.43 | 2.55 | 9.74 | 1.58 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.72 | 0.79 | 0.78 | 1.03 | 1.31 |
| Receivable days | 138.92 | 125.11 | 102.77 | 103.03 | 120.72 |
| Inventory Days | 7.13 | 9.21 | 13.72 | 24.29 | 35.14 |
| Payable days | 153.61 | 204.43 | 269.21 | 297.22 | 71.84 |
| Valuation Parameters | |||||
| PER(x) | 42.94 | 20.81 | 35.47 | 34.21 | 148.95 |
| PCE(x) | 37.04 | 18.38 | 30.11 | 21.83 | 44.14 |
| Price/Book(x) | 3.56 | 1.49 | 1.92 | 0.99 | 1.07 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 4.14 | 1.57 | 2.38 | 1.87 | 2.54 |
| EV/Core EBITDA(x) | 22.23 | 10.64 | 20.26 | 16.02 | 29.75 |
| EV/EBIT(x) | 25.17 | 12.85 | 24.82 | 21.33 | 53.12 |
| EV/CE(x) | 3.07 | 1.01 | 1.30 | 0.63 | 0.95 |
| M Cap / Sales | 4.06 | 1.56 | 2.29 | 1.83 | 2.35 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 10.58 | 22.20 | 66.71 | 28.51 | -35.36 |
| Core EBITDA Growth(%) | 39.19 | 53.96 | 68.00 | 75.65 | -59.73 |
| EBIT Growth(%) | 48.51 | 56.20 | 82.53 | 135.57 | -72.44 |
| PAT Growth(%) | 63.90 | 33.30 | 64.97 | 347.34 | -78.01 |
| EPS Growth(%) | 35.41 | 41.82 | 99.55 | 334.33 | -78.13 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.18 | 0.15 | 0.15 | 0.12 | 0.11 |
| Current Ratio(x) | 2.27 | 1.84 | 1.65 | 1.10 | 2.54 |
| Quick Ratio(x) | 2.21 | 1.81 | 1.57 | 1.05 | 2.29 |
| Interest Cover(x) | 4.21 | 3.36 | 8.22 | 6.84 | 2.71 |
| Total Debt/Mcap(x) | 0.05 | 0.10 | 0.08 | 0.12 | 0.10 |
Compare Financial Ratios of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹787.5 Cr | 1.6% | -5.6% | 36.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹389,172.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,248.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
| CIPLA | ₹122,835.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,869.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 1.6% |
-5.6% |
36.2% |
| SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses
